{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:39:45Z","timestamp":1784565585830,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801692"],"award-info":[{"award-number":["81801692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SS201808"],"award-info":[{"award-number":["SS201808"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS2020125"],"award-info":[{"award-number":["SYS2020125"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nuclear protein Ki-67 indicates the status of cell proliferation and has been regarded as an attractive biomarker for the prognosis of HCC. The aim of this study is to investigate which radiomics model derived from different sequences and phases of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI was superior to predict Ki-67 expression in hepatocellular carcinoma (HCC), then further to validate the optimal model for preoperative prediction of Ki-67 expression in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 151 (training cohort: n\u2009=\u2009103; validation cohort: n\u2009=\u200948) pathologically confirmed HCC patients. Radiomics features were extracted from the artery phase (AP), portal venous phase (PVP), hepatobiliary phase (HBP), and T2-weighted (T2W) images. A logistic regression with the least absolute shrinkage and selection operator (LASSO) regularization was used to select features to build a radiomics score (Rad-score). A final combined model including the optimal Rad-score and clinical risk factors was established. Receiver operating characteristic (ROC) curve analysis, Delong test and calibration curve were used to assess the predictive performance of the combined model. Decision cure analysis (DCA) was used to evaluate the clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The AP radiomics model with higher decision curve indicating added more net benefit, gave a better predictive performance than the HBP and T2W radiomic models. The combined model (AUC\u2009=\u20090.922 vs. 0.863) including AP Rad-score and serum AFP levels improved the predictive performance more than the AP radiomics model (AUC\u2009=\u20090.873 vs. 0.813) in the training and validation cohort. Calibration curve of the combined model showed a good agreement between the predicted and the actual probability. DCA of the validation cohort revealed that at a range threshold probability of 30\u201360%, the combined model added more net benefit compared with the AP radiomics model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A combined model including AP Rad-score and serum AFP levels based on enhanced MRI can preoperatively predict Ki-67 expression in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-021-00633-0","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T04:03:02Z","timestamp":1623729782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Yanfen","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-1802","authenticated-orcid":false,"given":"Chunhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"6","key":"633_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"633_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0b013e3182111195","volume":"253","author":"ST Fan","year":"2011","unstructured":"Fan ST, Lo CM, Poon RTP, Yeung C, Liu CL, Yuen WK, Lam CM, Ng KKC, Chan SC. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma A 20-year experience. Ann Surg. 2011;253(4):745\u201358.","journal-title":"Ann Surg"},{"issue":"5","key":"633_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","volume":"261","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947\u201355.","journal-title":"Ann Surg"},{"issue":"3","key":"633_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311\u201322.","journal-title":"J Cell Physiol"},{"issue":"5","key":"633_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s12094-017-1774-3","volume":"20","author":"C Yang","year":"2018","unstructured":"Yang C, Zhang J, Ding M, Xu K, Li L, Mao L, Zheng J. Ki67 targeted strategies for cancer therapy. Clin Transl Oncol. 2018;20(5):570\u20135.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"633_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/hepr.12487","volume":"45","author":"K Murakami","year":"2015","unstructured":"Murakami K, Kasajima A, Kawagishi N, Ohuchi N, Sasano H. Microvessel density in hepatocellular carcinoma: prognostic significance and review of the previous published work. Hepatol Res. 2015;45(12):1185\u201394.","journal-title":"Hepatol Res"},{"issue":"13","key":"633_CR7","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1245\/s10434-012-2461-9","volume":"19","author":"CT Sofocleous","year":"2012","unstructured":"Sofocleous CT, Garg S, Petrovic LM, Gonen M, Petre EN, Klimstra DS, Solomon SB, Brown KT, Brody LA, Covey AM, et al. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol. 2012;19(13):4262\u20139.","journal-title":"Ann Surg Oncol"},{"key":"633_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2147\/CMAR.S162595","volume":"10","author":"C Yang","year":"2018","unstructured":"Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O\u2019Brien SJ, Peng T. Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res. 2018;10:679\u201396.","journal-title":"Cancer Manag Res"},{"issue":"7","key":"633_CR9","first-page":"10235","volume":"8","author":"Y Luo","year":"2015","unstructured":"Luo Y, Ren F, Liu Y, Shi Z, Tan Z, Xiong H, Dang Y, Chen G. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis. Int J Clin Exp Med. 2015;8(7):10235\u201347.","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"633_CR10","first-page":"13083","volume":"8","author":"W Shi","year":"2015","unstructured":"Shi W, Hu J, Zhu S, Shen X, Zhang X, Yang C, Gao H, Zhang H. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis. Int J Clin Exp Pathol. 2015;8(10):13083\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7 Pt 2","key":"633_CR11","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/j.1440-1746.2008.05340.x","volume":"23","author":"N Mitsuhashi","year":"2008","unstructured":"Mitsuhashi N, Kobayashi S, Doki T, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, et al. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(7 Pt 2):e189\u201397.","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"633_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/modpathol.3800458","volume":"18","author":"G Guzman","year":"2005","unstructured":"Guzman G, Alagiozian-Angelova V, Layden-Almer JE, Layden TJ, Testa G, Benedetti E, Kajdacsy-Balla A, Cotler SJ. p53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol. 2005;18(11):1498\u2013503.","journal-title":"Mod Pathol"},{"issue":"4","key":"633_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441\u20136.","journal-title":"Eur J Cancer"},{"issue":"9","key":"633_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30(9):1234\u201348.","journal-title":"Magn Reson Imaging"},{"issue":"8","key":"633_CR15","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1007\/s00330-018-5986-x","volume":"29","author":"S Chen","year":"2019","unstructured":"Chen S, Feng S, Wei J, Liu F, Li B, Li X, Hou Y, Gu D, Tang M, Xiao H, et al. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol. 2019;29(8):4177\u201387.","journal-title":"Eur Radiol"},{"issue":"4","key":"633_CR16","first-page":"5084","volume":"16","author":"MW Juan","year":"2018","unstructured":"Juan MW, Yu J, Peng GX, Jun LJ, Feng SP, Fang LP. Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer. Oncol Lett. 2018;16(4):5084\u201390.","journal-title":"Oncol Lett"},{"issue":"2","key":"633_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00330-018-5575-z","volume":"29","author":"J Wei","year":"2019","unstructured":"Wei J, Yang G, Hao X, Gu D, Tan Y, Wang X, Dong D, Zhang S, Wang L, Zhang H, et al. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Eur Radiol. 2019;29(2):877\u201388.","journal-title":"Eur Radiol"},{"issue":"4","key":"633_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/jmri.26301","volume":"49","author":"Q Wu","year":"2019","unstructured":"Wu Q, Shi D, Dou S, Shi L, Liu M, Dong L, Chang X, Wang M. Radiomics analysis of multiparametric MRI evaluates the pathological features of cervical squamous cell carcinoma. J Magn Reson Imaging. 2019;49(4):1141\u20138.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"633_CR19","first-page":"041303","volume":"4","author":"S Bakr","year":"2017","unstructured":"Bakr S, Echegaray S, Shah R, Kamaya A, Louie J, Napel S, Kothary N, Gevaert O. Noninvasive radiomics signature based on quantitative analysis of computed tomography images as a surrogate for microvascular invasion in hepatocellular carcinoma: a pilot study. J Med Imaging (Bellingham). 2017;4(4):041303.","journal-title":"J Med Imaging (Bellingham)"},{"issue":"3","key":"633_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5152\/dir.2018.17467","volume":"24","author":"J Peng","year":"2018","unstructured":"Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol. 2018;24(3):121\u20137.","journal-title":"Diagn Interv Radiol"},{"issue":"10","key":"633_CR21","doi-asserted-by":"publisher","first-page":"813.e819","DOI":"10.1016\/j.crad.2019.06.024","volume":"74","author":"Y Li","year":"2019","unstructured":"Li Y, Yan C, Weng S, Shi Z, Sun H, Chen J, Xu X, Ye R, Hong J. Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma. Clin Radiol. 2019;74(10):813.e819\u201327.","journal-title":"Clin Radiol"},{"issue":"5","key":"633_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.21147\/j.issn.1000-9604.2019.05.10","volume":"31","author":"Z Ye","year":"2019","unstructured":"Ye Z, Jiang H, Chen J, Liu X, Wei Y, Xia C, Duan T, Cao L, Zhang Z, Song B. Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: a prospective study. Chin J Cancer Res. 2019;31(5):806\u201317.","journal-title":"Chin J Cancer Res"},{"issue":"21","key":"633_CR23","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"633_CR24","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1038\/s41598-019-45766-z","volume":"9","author":"M Schwier","year":"2019","unstructured":"Schwier M, van Griethuysen J, Vangel MG, Pieper S, Peled S, Tempany C, Aerts H, Kikinis R, Fennessy FM, Fedorov A. Repeatability of multiparametric prostate MRI radiomics features. Sci Rep. 2019;9(1):9441.","journal-title":"Sci Rep"},{"issue":"7","key":"633_CR25","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3109\/0284186X.2013.812798","volume":"52","author":"RT Leijenaar","year":"2013","unstructured":"Leijenaar RT, Carvalho S, Velazquez ER, van Elmpt WJ, Parmar C, Hoekstra OS, Hoekstra CJ, Boellaard R, Dekker AL, Gillies RJ, et al. Stability of FDG-PET radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol. 2013;52(7):1391\u20137.","journal-title":"Acta Oncol"},{"issue":"12","key":"633_CR26","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s00432-019-03062-3","volume":"145","author":"X Huang","year":"2019","unstructured":"Huang X, Long L, Wei J, Li Y, Xia Y, Zuo P, Chai X. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol. 2019;145(12):2995\u20133003.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"633_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.12120826","volume":"266","author":"MS Davenport","year":"2013","unstructured":"Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, Maturen KE, Chenevert TL, Hussain HK. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology. 2013;266(2):452\u201361.","journal-title":"Radiology"},{"issue":"9","key":"633_CR28","doi-asserted-by":"publisher","first-page":"800.e801","DOI":"10.1016\/j.crad.2017.03.013","volume":"72","author":"H Li","year":"2017","unstructured":"Li H, Xiao Y, Wang S, Li Y, Zhong X, Situ W, Xiao E, Zhang Z. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA. Clin Radiol. 2017;72(9):800.e801\u20136.","journal-title":"Clin Radiol"},{"key":"633_CR29","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.","journal-title":"Nat Commun"},{"issue":"12","key":"633_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-021-00633-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T04:05:35Z","timestamp":1623729935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-021-00633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1186\/s12880-021-00633-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-89492\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee (IRB) at the First Affiliated Hospital of Soochow University approved this retrospective study.  And the need to obtain the informed consent was waived by the IRB because of de-identification data involving no potential risk to patients and no link between the patients and researchers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}